Influence of a Single Dose Dexamethasone on the Time Course of Neuromuscular Blockade of Rocuronium
NCT01782820 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 108
Last updated 2022-08-17
Summary
The aim of the present study is to compare the time course of a neuromuscular block in patients receiving dexamethasone 8 mg in order to reduce postoperative nausea or vomiting several hours before surgery with patients receiving the drug immediately before induction of anaesthesia and patients without a dexamethasone prophylaxis. The primary end point is the time from start of injection of rocuronium until recovery to a train of four ratio (TOF ratio) of 0.9.
Conditions
- Neuromuscular Block, Dexamethasone
- Neuromuscular Block, Recovery
Sponsors & Collaborators
-
Kreiskrankenhaus Dormagen
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-12-31
- Primary Completion
- 2013-01-31
- Completion
- 2013-01-31
Countries
- Germany
Study Locations
More Related Trials
-
Effect of Magnesium Sulphate on Neostigmine
NCT03020706 ·Status: UNKNOWN ·Phase: NA
-
Neostigmine Reversal And Neuromuscular Recovery
NCT02433808 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Pharmacology Study to Evaluate the Effect of GYM329 on Disuse Muscle Atrophy in Healthy Volunteer
NCT04708847 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Pretreatment With Roc on Succinylcholine Myalgias
NCT04581395 ·Status: COMPLETED ·Phase: PHASE3
-
Oral Dexamethasone for the Treatment of Cervical Radiculopathy
NCT00308594 ·Status: TERMINATED ·Phase: PHASE2
-
Sugammadex Versus Neostigmine for Reversal of Rocuronium Neuromuscular
NCT03322657 ·Status: COMPLETED ·Phase: PHASE4
-
Sugammadex and Neostigmine at Shallow Neuromuscular Blockade
NCT00895609 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Pyridostigmine (Mestinon) on Muscle Strength in Myasthenia Gravis
NCT03510546 ·Status: UNKNOWN ·Phase: PHASE4
-
Dantrolene in Statin-induced Myopathy
NCT06966843 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Pharmacological Intervention in Insulin Resistance Targeting Autonomic Nerve Activity
NCT00689208 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Acute Unilateral Vestibulopathy and Corticosteroid Treatment
NCT02912182 ·Status: TERMINATED ·Phase: PHASE4
-
Glucocorticosteroid Treatment in Acute Unilateral Vestibulopathy (Vestibular Neuronitis)
NCT05024448 ·Status: COMPLETED ·Phase: PHASE4
-
Ephedrine for Reducing Onset Time of Rocurinium in Elderly Patients
NCT06681662 ·Status: RECRUITING ·Phase: PHASE4
-
Safety and Efficacy Study of Pyridostigmine on Patients With Spinal Muscular Atrophy Type 3
NCT02227823 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Sugammadex Dosed According to Actual Body Weight (ABW) or Ideal Body Weight (IBW) in Reversal of Neuromuscular Blockade (NMB) in Morbidly Obese Participants (MK-8616-146)
NCT03346070 ·Status: COMPLETED ·Phase: PHASE4
-
Reversal of Neuromuscular Blockade in Thoracic Surgical Patients
NCT01837498 ·Status: COMPLETED
-
The Dose-Response Relationship of Rocuronium in Patients Taking Pyridostigmine
NCT02157545 ·Status: WITHDRAWN
-
Reversal of Neuromuscular Blockade During the General Anaesthesia
NCT04048655 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Effect of Sugammadex Versus Neostigmine During Neuromuscular Blockade Reversal
NCT03579589 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluate the Neurological Effects of EryDex on Subjects With A-T
NCT06193200 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Neuromuscular Blockade and Reversal on Breathing
NCT02845375 ·Status: COMPLETED ·Phase: PHASE4
-
Neostigmine/Glyco-pyrrolate 50 Mikrogram/kg or Sugammadex 2 mg/kg for Reversal of Neuromuscular Blockade in Elderly Patients
NCT06228092 ·Status: COMPLETED ·Phase: PHASE4
-
Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Telangiectasia Patients
NCT02770807 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex® (Tizanidine Hydrochloride Tablets) Taken While in the Fed State (Just After a Meal) and in the Fasted State (Before a Meal) in Patients With Moderate to Severe Spasticity.
NCT00047580 ·Status: COMPLETED ·Phase: PHASE3
-
Sugammadex Improves Muscle Function After Standard Neuromuscular Recovery
NCT01101139 ·Status: COMPLETED ·Phase: PHASE4